�鶹��ýӰ��

Greg Laub

Greg Laub

Authors >

Greg Laub

Greg Laub joined MedPage Today in 2005 as Production Manager and led the launch of the video department in 2007. He currently leads the video and podcast production teams. Greg's passion to craft a story began as a writer, with stops as Managing Editor at USOpen.org, Creative Director at Bernard Hodes Advertising, and copywriter at AOL Time Warner. He's even had one of his screenplays produced -- he believes it was beloved by all seven people who saw it. Greg lives in New Jersey with his wife, two kids and two dogs.

Connect:

email image

Latest from Greg Laub

Benefits of Drug Combo in Myeloma Maintenance Shown in Relevant Subgroups

MRD-negativity rates improved across subgroups, supporting daratumumab-lenalidomide combination

Pain, Fatigue Benefits May Give Resistance Training a Leg Up in Multiple Myeloma

Structured exercise improves fatigue and pain but requires long-term patient commitment

Masking Policies Show Clear Impact on Hospital-Onset Respiratory Infections

Study links lifting and reintroducing masking policies to infection rate changes

Fostamatinib Fails to Improve Outcomes in Hypoxemic COVID Patients

Drug did not increase oxygen-free days versus placebo in randomized study

Modified Donanemab Dosing May Reduce ARIA-E Risk in Early Alzheimer's

And regimen still maintained sufficient amyloid reduction

Novel Therapies for Asthma in the Pipeline

"A lot of areas in which we're going to see a lot of improvements," says Michael E. Wechsler, MD

AREDS2 Supplements and Geographic Atrophy Progression

Emily Chew, MD, explains how diet and key nutrients shape AMD management strategies

International Working Group Discusses Diagnosing Alzheimer's Disease

Proposed framework has biological and clinical components

Barzolvolimab Shows Promise for Cold Urticaria and Dermographism

Improved provocation test outcomes and symptom control in phase II study

AREDS Supplements May Slow Geographic Atrophy Progression Toward the Fovea

Post hoc analysis sparks discussion on their role in GA treatment and clinical trials

2

…